- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Copper Chloride.
Displaying page 1 of 1.
EudraCT Number: 2019-000905-57 | Sponsor Protocol Number: wilson12345 | Start Date*: 2019-04-17 | |||||||||||
Sponsor Name:The Department of Hepatology and Gastroenterology, Aarhus University Hospital | |||||||||||||
Full Title: Efficacy of zinc on human gut copper uptake depending on zinc type and dose regimen quantified with 64CuCl2 PET/CT-scan | |||||||||||||
Medical condition: Healthy volunteers (Wilson's disease) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002678-19 | Sponsor Protocol Number: SP148MP201 | Start Date*: 2018-03-20 | |||||||||||
Sponsor Name:SmartPractice | |||||||||||||
Full Title: Clinical Evaluation of Metal Panel Allergens: Aluminum, Copper, Manganese, Molybdenum, Tin, Titanium, Vanadium and Zinc Dose Response Study | |||||||||||||
Medical condition: Metal induced contact dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000102-25 | Sponsor Protocol Number: ALXN1840-WD-Cu-Excretion | Start Date*: 2021-04-09 | |||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||
Full Title: Efficacy of ALXN1840 on human biliary copper excretion quantified with 64CuCl2 PET/MR-scan | |||||||||||||
Medical condition: Wilson's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-005464-21 | Sponsor Protocol Number: DiagnosingWD-PET/MR-pilot | Start Date*: 2022-07-07 | ||||||||||||||||
Sponsor Name:Aarhus University Hospital | ||||||||||||||||||
Full Title: Diagnosing Wilson’s Disease with 64-Cu PET/MR – A Pilot Study | ||||||||||||||||||
Medical condition: Wilson's disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-004748-62 | Sponsor Protocol Number: 05PF2005 | Start Date*: 2021-12-17 | |||||||||||
Sponsor Name:Q-Med AB, part of the Galderma Group | |||||||||||||
Full Title: A Phase IV, Randomized, Interventional, Study to Assess Subject Treatment Session Perception and Investigator Treatment Experience of Alluzience and Vacuum-Dried Botulinum Neurotoxin Type A for ... | |||||||||||||
Medical condition: Moderate to severe glabellar lines (GL). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.